CD163 and glioma: Hu et al. reported LGALS3 as an independent poor prognostic marker in diffusely infiltrating gliomas and it was also positively correlated with immune cell infiltration, particularly CD163+ tumor-associated macrophages in the TCGA dataset, Rembrandt dataset, and their SYSUCC cohort [55].